BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 16542182)

  • 21. COMT val158Met and executive control: a test of the benefit of specific deficits to translational research.
    MacDonald AW; Carter CS; Flory JD; Ferrell RE; Manuck SB
    J Abnorm Psychol; 2007 May; 116(2):306-12. PubMed ID: 17516763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Catechol-O-methyltransferase Val158Met polymorphism affects therapeutic response to mood stabilizer in symptomatic manic patients.
    Lee HY; Kim YK
    Psychiatry Res; 2010 Jan; 175(1-2):63-6. PubMed ID: 20004480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Catechol-O-methyltransferase (COMT) genotype moderates the effects of childhood trauma on cognition and symptoms in schizophrenia.
    Green MJ; Chia TY; Cairns MJ; Wu J; Tooney PA; Scott RJ; Carr VJ;
    J Psychiatr Res; 2014 Feb; 49():43-50. PubMed ID: 24252819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The flexible mind is associated with the catechol-O-methyltransferase (COMT) Val158Met polymorphism: evidence for a role of dopamine in the control of task-switching.
    Colzato LS; Waszak F; Nieuwenhuis S; Posthuma D; Hommel B
    Neuropsychologia; 2010 Jul; 48(9):2764-8. PubMed ID: 20434465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COMT Val108/158 Met modifies mismatch negativity and cognitive function in 22q11 deletion syndrome.
    Baker K; Baldeweg T; Sivagnanasundaram S; Scambler P; Skuse D
    Biol Psychiatry; 2005 Jul; 58(1):23-31. PubMed ID: 15935994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The catechol O-methyltransferase Val158Met polymorphism is not associated with broad-based cognitive functioning in schizophrenia.
    Dickerson FB; Boronow JJ; Stallings C; Origoni AE; Sullens A; Yolken RH
    Schizophr Res; 2007 Nov; 96(1-3):87-92. PubMed ID: 17601704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Catechol O-methyltransferase Val158Met polymorphism is associated with cognitive performance in nondemented adults.
    de Frias CM; Annerbrink K; Westberg L; Eriksson E; Adolfsson R; Nilsson LG
    J Cogn Neurosci; 2005 Jul; 17(7):1018-25. PubMed ID: 16102234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Catechol-O-methyltransferase Val158Met polymorphism in relation to aggressive schizophrenia in a Korean population.
    Kim YR; Kim JH; Kim SJ; Lee D; Min SK
    Eur Neuropsychopharmacol; 2008 Nov; 18(11):820-5. PubMed ID: 18789857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The risk of posttraumatic stress disorder after trauma depends on traumatic load and the catechol-o-methyltransferase Val(158)Met polymorphism.
    Kolassa IT; Kolassa S; Ertl V; Papassotiropoulos A; De Quervain DJ
    Biol Psychiatry; 2010 Feb; 67(4):304-8. PubMed ID: 19944409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COMT polymorphisms as predictors of cognitive dysfunction during manic and mixed episodes in bipolar I disorder.
    Soeiro-de-Souza MG; Machado-Vieira R; Soares Bio D; Do Prado CM; Moreno RA
    Bipolar Disord; 2012 Aug; 14(5):554-64. PubMed ID: 22713126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COMT and BDNF interacted in bipolar II disorder not comorbid with anxiety disorder.
    Lee SY; Chen SL; Wang YS; Chang YH; Huang SY; Tzeng NS; Lee IH; Yeh TL; Yang YK; Lu RB
    Behav Brain Res; 2013 Jan; 237():243-8. PubMed ID: 23026378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Catechol O-methyltransferase and monoamine oxidase A genotypes, and plasma catecholamine metabolites in bipolar and schizophrenic patients.
    Zumárraga M; Dávila R; Basterreche N; Arrue A; Goienetxea B; Zamalloa MI; Erkoreka L; Bustamante S; Inchausti L; González-Torres MA; Guimón J
    Neurochem Int; 2010; 56(6-7):774-9. PubMed ID: 20206656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association study of COMT gene Val158Met polymorphism with auditory P300 and performance on neurocognitive tests in patients with schizophrenia and their relatives.
    Golimbet V; Gritsenko I; Alfimova M; Lebedeva I; Lezheiko T; Abramova L; Kaleda V; Ebstein R
    World J Biol Psychiatry; 2006; 7(4):238-45. PubMed ID: 17071544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum antibodies to Toxoplasma gondii and Herpesvidae family viruses in individuals with schizophrenia and bipolar disorder: a case-control study.
    Tedla Y; Shibre T; Ali O; Tadele G; Woldeamanuel Y; Asrat D; Aseffa A; Mihret W; Abebe M; Alem A; Medhin G; Habte A
    Ethiop Med J; 2011 Jul; 49(3):211-20. PubMed ID: 21991754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The high-activity Val allele of the catechol-O-methyltransferase gene predicts greater cognitive deterioration in patients with psychosis.
    Mata I; Arranz MJ; Staddon S; Lopez-Ilundain JM; Tabares-Seisdedos R; Murray RM
    Psychiatr Genet; 2006 Oct; 16(5):213-6. PubMed ID: 16969277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association study of a functional catechol-O-methyltransferase polymorphism and executive function in elderly males without dementia.
    Liu ME; Hong CJ; Liou YJ; Tsai YL; Hsieh CH; Tsai SJ
    Neurosci Lett; 2008 May; 436(2):193-5. PubMed ID: 18387741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Catechol-o-methyltransferase (COMT) and proline dehydrogenase (PRODH) mRNAs in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and major depression.
    Tunbridge E; Burnet PW; Sodhi MS; Harrison PJ
    Synapse; 2004 Feb; 51(2):112-8. PubMed ID: 14618678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Catechol-O-methyltransferase gene and obsessive-compulsive symptoms in patients with recent-onset schizophrenia: preliminary results.
    Zinkstok J; van Nimwegen L; van Amelsvoort T; de Haan L; Yusuf MA; Baas F; Linszen D
    Psychiatry Res; 2008 Jan; 157(1-3):1-8. PubMed ID: 17850881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of catechol-O-methyltransferase Val158Met polymorphism by a simple one-step tetra-primer amplification refractory mutation system-PCR.
    Ruiz-Sanz JI; Aurrekoetxea I; Ruiz del Agua A; Ruiz-Larrea MB
    Mol Cell Probes; 2007 Jun; 21(3):202-7. PubMed ID: 17337160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Catechol-O-methyltransferase val158met and cognitive function in Parkinson's disease.
    Hoogland J; de Bie RM; Williams-Gray CH; Muslimović D; Schmand B; Post B
    Mov Disord; 2010 Nov; 25(15):2550-4. PubMed ID: 20878993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.